Legal & General Group
ARMP icon

Legal & General Group’s Armata Pharmaceuticals ARMP Stock Holding History

Legal & General Group’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.52K Buy
+1,161
New +$10.6K ﹤0.01% 3342

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Legal & General Group's ARMP Position: Q2 2026 in Review

Legal & General Group opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 1,161 shares worth $7.52K. The stake represents ﹤0.01% of the portfolio and ranks #3342 among its holdings.

53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Legal & General Group held 1,161 shares of Armata Pharmaceuticals worth $7.52K as of Q2 2026.
  • Armata Pharmaceuticals was a new Legal & General Group position in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3342 holding.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.